Immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in familial clustering of gastric cancer

Journal of Surgical Oncology

Volumn 62, Issue 4, 1996, Pages 253-257

  Okusa, Yasushi ^a   Ichikura, Takashi ^a   Tamakuma, Shoetsu ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

familial factor; gastric cancer with family history; p53 mutation

Indexed keywords

CYCLINE; PROTEIN P53;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029747037     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199608)62:4<253::AID-JSO5>3.0.CO;2-5     Document Type: Article

References (36)

1. Hoshino H, Hirayama T, Arimoto H, et al.: Gastric cancer risk factors: A case-control study based on medical records. Jpn J Cancer Res 76:846-850, 1985.
2. Mirvish SS: The etiology of gastric cancer. Intragastric nitrosamide formation and other theories. J Natl Cancer Inst 71:629-647,1983.
3. Hirayama T: Epidemiology of stomach cancer in Japan with special reference to the strategy for the primary prevention. Jpn J Clin Oncol 14:159-168, 1984.
4. Tajima K, Tominaga S: Dietary habits and gastrointestinal cancers: a comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan. Jpn J Cancer Res 76:705-716, 1985.
5. Srivastava S, Zou ZQ, Pirollo K, et al.: Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747-749, 1990.
6. Malkin D, Li FP, Strong LC, et al.: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238, 1990.
7. Li FP, Fraumeni JF: Soft-tissue sarcomas, breast cancer, and other neoplasms: A familial syndrome? Ann Intern Med 71:747-752, 1969.
8. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancer. Science 253:49-53, 1991.
9. Baker SJ, Preisinger AC, Jessup JM, et al.: p53 gene mutations occur in combination with 17q allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50:7717-7722, 1990.
10. Baker SJ, Markowitz S, Fearon ER, et al.: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 2 49:912-915, 1990.
11. Thor AD, Moore II DH, Edgerton SM, et al.: Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. J Natl Cancer Inst 84:845-855, 1992.
12. Iwaya K, Tsuda H, Hiraide H, et al.: Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. Jpn J Cancer Res 82:835-840, 1991.
13. Moll UM, Riou G, Levine AJ: Two distinct mechanisms alter p53 in breast cancer: Mutation and nuclear exclusion. Proc Natl Acad Sci USA 89:7262-7266, 1992.
14. Cattoretti G, Rulke F, Andreola S, et al.: p53 expression in breast cancer, Int J Cancer 41:178-183, 1988.
15. Walker RA, Dearing SJ, Lane DP, Varley JM: Expression of p53 protein in infiltrating and in-situ breast carcinomas. J Pathol 165:203-211, 1991.
16. Ostrowski JL, Sawan A, Henry L, et al.: p53 expression in human breast cancer related to survival and prognostic factors: An immunohistochemical study. J Pathol 164:75-81, 1991.
17. Purdie CA, O'Grady J, Pins J, et al.: p53 expression in colorectal tumors. Am J Pathol 138:807-813, 1991.
18. Suzuki H, Matsumoto K, Koide A, et al.: Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma. Jpn J Surg 24:85-87, 1994.
19. Starzynska T, Bromley M, Ghosh A, Stern PL: Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 66:558-562, 1992.
20. Martin HM, Filipe MI, Morris RW, et al.: p53 expression and prognosis in gastric carcinoma. Int J Cancer 50:859-862, 1992.
21. Lipponen PK: Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int J Cancer 53:365-370, 1993.
22. Visakorpi T, Kallioniemi OP, Heikkinen A, et al.: Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J Natl Cancer Inst 84:883-887, 1992.
23. Frank JL, Bur ME, Garb JL, et al.: p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer 73:181-186, 1994.
24. Shin DM, Kim J, Ro JY, et al.: Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54:321-326, 1994.
25. Barbareschi M, Iuzzolino P, Pennella A, et al.. p53 protein expression in central nervous system neoplasms. J Clin Pathol 45:583-586, 1992.
26. Frankel RH, Bayona W, Koslow M, Newcomb EW: p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res 52:1427-1433, 1992.
27. Ellison DW, Gatter KC, Steart PV, et al.: Expression of the p53 protein in a spectrum of astrocytic tumours. J Pathol 168:383-386, 1992.
28. Japanese Research Society for Gastric Cancer: "Japanese Classification of Gastric Carcinoma." Tokyo: Kanehara, 1995.
29. Finlay CA, Hinds PW, Levine AJ: The p53 protooncogene can act as a suppressor of transformation. Cell 57:1083-1093, 1989.
30. Bartek J, Iggo R, Gannon J, et al.: Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5:893-899, 1990.
31. Finlay CA, Hinds PW, Tan TH, et al.: Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-p53 complex with an altered half-life. Mol Cell Biol 8:531-539, 1988.
32. Iggo R, Gatter K, Bartek J, et al.: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675-679, 1990.
33. Davidoff AM, Humphrey PA, Iglehart JD, Marks JR: Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA 88:5006-5010, 1991.
34. Marchetti A, Buttitta F, Pellegrini S, et al.: Mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations. Diagn Mol Pathol 4:93-97, 1995.
35. Mercer WE, Shields MT, Lin D, et al.: Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc Natl Acad Sci USA 88:1958-1962, 1991.
36. Pignatelli M, Stamp GWH, Kafiri G, et al.: Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer 50:683-688, 1992.